The Financialization of Disruptive Technology
The Agile Manager
SEPTEMBER 30, 2019
What if this is not a viable strategy? A recent FT Lex article on biotech investing drives the point home: "A 20-year study found only one-fifth of exits were profitable. It's fashionable to champion an investment-oriented model for software development, particularly around exploratory opportunities. Allocate risk capital, run experiments through software, learn what works and what doesn't work, re-focus, rinse, repeat, reap rewards.